FDA’s tobacco program must be proactive, not reactive, independent panel says after extensive review
CNN — An independent panel of experts says its review of the US Food and Drug Administration’s tobacco program found numerous wide-ranging problems that hinder its ability to regulate the industry and reduce tobacco-related disease and death. FDA Commissioner Dr. Robert Califf requested the review in July, anticipating the complex issues that will come with …